Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.
Saved in:
| Title: | Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy. |
|---|---|
| Authors: | Schulz M; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Levy DI; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Petropoulos CJ; Labcorp-Monogram Biosciences, South San Francisco, CA 94080, USA., Bashirians G; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Winburn I; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Mahn M; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Somanathan S; Pfizer, 235 East 42nd Street, New York, NY 10017, USA. Electronic address: suryanarayan.somanathan@pfizer.com., Cheng SH; Pfizer, 235 East 42nd Street, New York, NY 10017, USA., Byrne BJ; University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA. Electronic address: barry.byrne@ufl.edu. |
| Source: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Mar 01; Vol. 31 (3), pp. 616-630. Date of Electronic Publication: 2023 Jan 11. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1525-0024 |
|---|---|
| DOI: | 10.1016/j.ymthe.2023.01.010 |
